More Updates to Come of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial: Could the Statistical Methodology Be Further Improved?

Autor: Tong WH; Wing H. Tong, MD, PhD, MSc, Department of Public Health and Primary Care (PHEG), Leiden University Medical Center, Leiden, the Netherlands, Argos Zorggroep 'DrieMaasStede,' Center for Specialized Geriatric Care, Schiedam, the Netherlands; and Bart J. Mertens, PhD, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands., Mertens BJ; Wing H. Tong, MD, PhD, MSc, Department of Public Health and Primary Care (PHEG), Leiden University Medical Center, Leiden, the Netherlands, Argos Zorggroep 'DrieMaasStede,' Center for Specialized Geriatric Care, Schiedam, the Netherlands; and Bart J. Mertens, PhD, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
Jazyk: angličtina
Zdroj: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 May 01; Vol. 41 (13), pp. 2450-2451. Date of Electronic Publication: 2023 Mar 10.
DOI: 10.1200/JCO.22.02839
Databáze: MEDLINE